Fighting organ transplant rejections, St. Louis startup Antiger Therapeutics joins the battle
Biochemist Hungjie Guo, PhD, is always thinking about what she can do to make a difference.
Guo became an entrepreneur in 2020 as the founder of Tiger Biologics and later became co-founder of Antiger Therapeutics.
The companies are supporting the battle against diseases from the bench, and fighting for organ transplant patients, hoping to reduce transplant failures.
Antiger therapeutics is a biotechnology company working to develop precision immunotherapies for transplant recipients who reject their transplant. The company is also targeting therapies for autoimmune diseases, including Type 1 diabetes and celiac disease..#organdonation #organtransplant